GøtzschePCKassirerJPWoolleyKL. What should be done to tackle ghostwriting in the medical literature?PLOS Med. 2009;6(2):e1000023. Doi:10.1371/journal.pmed.1000023.
9.
GrafCBattistiWPBridgesD. Good publication practice for communicating company sponsored medical research: the GPP2 guidelines. BMJ. 2009;339:b4330.
10.
HealyDCattellD. Interface between authorship, industry and science in the domain of therapeutics. Br J Psychiatr. 2003;183:22-27.
11.
NgaiSGoldJLGillSSRochonPA. Haunted manuscripts: Ghost authorship in the medical literature. Accountability in Research. 2005;12:103-114.
12.
NorrisRBowmanAFaganJM. International Society for Medical Publication Professionals (ISMPP) position statement: the role of the professional medical writer. Curr Med Res Opin. 2007;23(8):1837-1840.
13.
ShapiroJS. Contested Will: Who Wrote Shakespeare?New York: Simon & Schuster, 2010.
14.
SingerN. Report urges more curbs on medical ghostwriting. New York Times. June24, 2010.
15.
SismondoSDoucetM. Publication ethics and the ghost management of medical publication. Bioethics. 2010;24(6):273-283.
16.
SteinmanMABeroLAChrenMLondefeldCS. Narrative review: The promotion of gabapentin: An analysis of internal industry documents. Ann Intern Med. 2006;145:284-293.
17.
Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Ethical considerations in the conduct and reporting of research: Authorship and contributorship. Available at http://www.icmje.org/ethical_1author.html. Accessed September 13, 2010.
